NIH RADx Initiative Advances Six New Covid-19 Testing Technologies
The addition of new, rapid point-of-care platforms will expand national testing options.
Read MorePosted by Laurie Bonner | Oct 6, 2020 | Company News, Covid 19 |
The addition of new, rapid point-of-care platforms will expand national testing options.
Read MorePosted by Laurie Bonner | Oct 6, 2020 | Company News, Covid 19 |
BioReference Labs shut down temporarily in July in a controversial move that helped it win new business and prepare for the coming flu season.
Read MorePosted by Laurie Bonner | Oct 6, 2020 | Covid 19, Molecular Diagnostics |
The assay is now authorized for asymptomatic individuals and symptomatic sample pooling.
Read MorePosted by Melanie Hamilton-Basich | Oct 5, 2020 | Biochemicals & Chemical Reagents, Covid 19 |
One lab that participated in NILA’s survey reports having enough reagent to process 500 tests per day, yet their covid-19 testing capacity is at least 3,000 tests per day.
Read MorePosted by Melanie Hamilton-Basich | Oct 5, 2020 | Compliance, Covid 19 |
Today, the FDA will host a virtual Town Hall for clinical laboratories and commercial manufacturers that are developing or have developed diagnostic tests for SARS-CoV-2.
Read More